Abstract

254P Effects of delaying adjuvant chemotherapy initiation on clinical outcomes in early triple-negative breast cancer patients

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract P6-08-46: Clinical outcomes of breast cancer patients with intermediate oncotype DX recurrence scores (RS): A review of the Cleveland Clinic Experience
Lindsey M Goodman ... Halle Moore
American Journal of Cancer | VOL. 75
Lindsey M Goodman, et. al.Lindsey M Goodman ... Halle Moore
30 Apr 2015
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients.
Oliver Hoffmann ... Rainer Kimmig
Frontiers in Immunologie | VOL. 14
Oliver Hoffmann, et. al.Oliver Hoffmann ... Rainer Kimmig
22 May 2023
Abstract P3-03-19: Real-world data of clinical characteristics, risk factors and outcomes of Chilean triple-negative breast cancer patients
... César Sánchez
American Journal of Cancer | VOL. 83
, et. al. ... César Sánchez
01 Mar 2023
Abstract P5-12-05: Clinical outcomes in early breast cancer patients on adjuvant tamoxifen: Impact of CYP2D6 genotype and observed endoxifen concentrations
Veera Durga Sravanthi Panuganty ... Francisco Perera
American Journal of Cancer | VOL. 80
Veera Durga Sravanthi Panuganty, et. al.Veera Durga Sravanthi Panuganty ... Francisco Perera
14 Feb 2020
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
Proofreading the way: immune checkpoint inhibitors in polymerase ε/polymerase δ (POLE/POLD1)-altered colorectal cancer
M Cecchini ... R Sundar
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
M Cecchini, et. al.M Cecchini ... R Sundar
01 Jul 2024
Table of Contents
-
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
--
01 Jul 2024
Editorial Board
-
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
--
01 Jul 2024
View more papers